| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.5 - Atopic Dermatitis, Diagnosed | 2014 | Korea, Republic of | IgE | 25 | 4.000 | 20140821, Choi JS
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2014 | Austria | IgE | 35 | 57.140 | 20141020, Guhsl EE
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 14.500 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 11.430 | 20130605, Simon D
| | 1.3 - Rhinitis, Diagnosed | 2013 | Brazil | IgE | 101 | 1.900 | 20130912, Lacerda Araujo LM
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2013 | Austria | IgE | 20 | 70.000 | 20130401, Berneder M
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 7.290 | 20120528, Patelis A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2012 | Japan | IgE | 93 | 56.990 | 20120130, Fukutomi Y
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2012 | Spain | IgE | 55 | 9.100 | 20120726, Pedrosa M
| | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 2012 | Spain | IgE | 68 | 5.900 | 20120726, Pedrosa M
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 42.420 | 20110223, De Knop KJ
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Japan | IgE | 21 | 100.000 | 20120130, Fukutomi Y
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 1.350 | 20120528, Patelis A
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Netherlands | IgE | 11 | 36.360 | 20110304, Vissers YM
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2011 | Netherlands | IgE | 9 | 100.000 | 20110304, Vissers YM
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 12.790 | 20101214, Gadisseur R
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 45.000 | 20091005, Ott H
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 4.550 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 50.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 0.000 | 20090826, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2008 | Germany | IgE | 50 | 72.000 | 20081129, Treudler R
| | 5.7.2 - Source Exposed (Provocation Test - Ingestion) | 2007 | Denmark / Italy / Switzerland | IgE | 30 | 70.000 | 20070323, Ballmer-Weber BK
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2006 | Germany | IgE | 16 | 25.000 | 20060711, Lin J
| | 5.2.4 - Source Exposed, Adults (Symptoms, IgE) | 2006 | Germany | IgE | 16 | 12.500 | 20060711, Lin J
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2004 | Switzerland | IgE | 94 | 71.300 | | | 5.1.1 - Source Exposed (Symptoms) | 2004 | Switzerland | IgE | 22 | 95.400 | | | 3.2.2 - Source Sensitized - High Exposure (IgE) | 2002 | Germany | IgE | 20 | 85.000 | |
|
Loading...
Gly m 4
